Chamber and committees

The Social Care Staff Support Fund was set up in June 2020 using emergency powers provided by the Coronavirus (No.2) (Scotland) Act. This provision is intended for a group of workers who, due to the nature of their work or work environment, may be expected to self-isolate on more than one occasion as part of infection prevention and control. The aforementioned emergency powers are due to expire on 30 September 2022, and my officials are currently scoping what support may be required beyond this date.

The Scottish Government has supported additional staffing costs, including the Social Care Staff Support Fund, through sustainability payment funding to Integration Authorities.

£561 million in 2020-21 and over £700 million in 2021-22 was allocated to Integration Authorities for social care Covid-19 support, including sustainability payments. While no further Barnett consequentials have been provided, the Scottish Government has continued funding a number of additional Covid-19 costs in 2022-23, providing funding for all costs associated with vaccinations and testing in care homes to 31 March 2023. The emergency legislation underpinning the Social Care Staff Support Fund is due to expire on 30 September 2022 and officials are currently reviewing options for support beyond this date.

The Scottish Government does not receive separate reporting relating to the cost of the Social Care Staff Support Fund for delegated services, and such information would require to be requested from Integration Authorities.

I refer the member to the answer to question S6W-08949 on 26 July 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

There are a range of options available to women who require transvaginal mesh removal surgery. A contract with Spire Healthcare, where Professor Hashim operates, was agreed earlier this year and arrangements for the first patients to travel to Bristol are underway. Furthermore, the Scottish Government can now also confirm that a contract has been agreed with Gynaecologic and Reconstructive Surgery Ltd, Missouri, USA, where Dr Veronikis operates. NHS National Services Scotland will now work closely with NHS GGC and local Health Boards to facilitate the arrangements for those who wish to travel to Bristol or to the USA for mesh removal surgery.

These additional options, alongside the potential for referral to NHS England services, complement the Complex Pelvic Mesh Removal Service in Glasgow. Despite Covid-19, we were able to introduce that service on a phased basis and a number of patients have been seen in the intervening period and have had surgeries carried out. It is expected that NHS Greater Glasgow and Clyde will work towards improving waiting times as services begin to open up more fully.

The Scottish Government launched the Social Care Staff Support Fund on 25 June 2020 to ensure that social care workers receive their expected income should they be off ill or self-isolating due to coronavirus.

Staffing costs claimed through sustainability payments encompass the Social Care Staff Support Fund, the staff movement policy and other additional staffing arrangements therefore, we do not have data broken down to the level that you have requested. The guidance for the financial support for social care providers recommends a light touch approach to gathering evidence, recognising the administrative burden of claiming additional costs on both commissioners and providers alike, whilst they respond to the pandemic.

Feedback from stakeholders confirms that the Social Care Staff Support Fund has been utilised to prevent financial hardship for eligible social care workers.

The Scottish Government expects the Bank to publish its Gender Equality Strategy later this summer. As part of a wider Equality Strategy, we expect this to set out the Bank’s approach to advancing equality in Scotland across its activities and in line with legislative requirements, including those of the Scottish National Investment Bank Act.

To date 10 patients have requested referral to either Dr Veronikis or Professor Hashim. It is possible, however, that this number will increase once the contract arrangements with Dr Veronikis have been finalised and the formal referral pathways are in place.

For complex mesh removal surgery, case review by a specialist multi-disciplinary team (MDT) is seen as pivotal in ensuring that all clinical considerations are taken into account in the planning of surgery which meets the needs of the patients. With the agreement of the independent providers, prior to referral, patients will be discussed by the MDT in Glasgow to ensure that they are fit for surgery and that all relevant diagnostic investigations have been undertaken. If, after careful consideration by both the MDT and the patient, it is agreed that surgery is appropriate and the patient wishes to be referred to either Dr Veronikis or Professor Hashim, the team in Glasgow will facilitate this in conjunction with their local specialist within their local Health Board who will then share in the ongoing care of the women following their surgery.

The contract negotiations with Dr Veronikis are progressing and are expected to reach a positive conclusion imminently. No patients can be referred until this process is complete, however referrals for those who wish to travel for treatment by Dr Veronikis will begin as soon as possible after the contract has been concluded. All negotiations with Spire Healthcare, Bristol are complete and contracts have been signed. For the small number of patients who have requested referral to Spire Healthcare, arrangements for referral are now beginning and it is anticipated that the first patients will travel for treatment shortly.

We recognise the impact long waiting times can have on a patient, from both a clinical and mental health perspective. At this stage in recovery from the pandemic, long-waiting patients must be considered a priority.

Work is underway, through the Care and Wellbeing Portfolio, to provide more active support to people whilst they are waiting for treatment. This will include the launch this summer of a national system that will provide information on waiting times by health board and by specialty.

More information on ‘waiting well’ and accessible services will also be made available for people to manage their conditions while they wait for treatment.